We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company

DAS srl

Devises and manufactures electronic automated instruments in the IVD field for full automation of ELISA, IFA, BLOT a... read more Featured Products: More products

Download Mobile App





DAS Srl Exhibits Range of Fully Automated Systems at MEDLAB Middle East 2020

By LabMedica International staff writers
Posted on 06 Feb 2020
Print article
Illustration
Illustration
DAS Srl (Lazio, Italy) displayed the AP22 IF BLOT ELITE system and its lineup of standalone instruments at MEDLAB Middle East, one of the world’s major events in the field of medical diagnostics that was held in Dubai World Trade Center and attended by thousands of visitors from over 135 countries.

At this year’s MEDLAB, DAS Srl displayed the AP 22 IF BLOT ELITE fully automated system for ELISA and IFA and BLOT methods which can run two ELISA micro-plates with eight tests on line, 16 IFA slides or 24 BLOT strips. In addition to ELISA and IFA processing (AP22, AP22 IF), it can carry out full automation for the Dot/Western Blot, thanks to the blot module and a camera, starting from sample dilution and dispense, reagent dispense, incubation, strip washing to the dot imaging processing and assessment for each strip.

DAS Srl also exhibited its lineup of standalone instruments, including PLATE READER, an eight channel photometer for sequential and simultaneous reading of micro-plate strips with 96 wells; PLATE WASHER, an automated washer for micro-plates with 96 wells featuring an original and versatile aspirate and dispense system that requires less than 3µl of residue washing liquid; and STRIP READER, a one channel photometer able that can read strips with 8/12 wells or part of them and is a mono and bi-chromatic reading system.

DAS Srl also displayed NEO-BIL Plus, an advanced and innovative version of traditional bilirubinometers for analyzing the 'total bilirubin' through a microcapillary tube without using reagents. It performs precise sample measurement of both bilirubin and interferentials on the same point of the capillary through a special reading system using a small quantity of serum. At MEDLAB 2020, DAS Srl exhibited the HB ANALYZER PLUS, a hemoglobinometer for fast and accurate determination of hemoglobin using the cyanmetahemoglobin method. The HB ANALYZER PLUS immediately displays the direct reading, expressed in concentration (g/l, g/dl, mmol/l).

Related Links:
DAS Srl

Gold Supplier
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
New
Gold Supplier
Virus Detection System
DRI-CHEM IMMUNO AG2
New
Hematology Reagents
Hematology Reagents
New
TSH (Thyroid Stimulating Hormone) Test
Kemilo TSH Kit

Print article

Channels

Clinical Chem.

view channel
Image: Brief schematic diagram of the detection principle and method (Photo courtesy of CAS)

Rapid, Non-Invasive Method Diagnoses Type 2 Diabetes by Sniffing Urinary Acetone

Over 90% of diabetes cases are attributed to Type 2 diabetes (T2D), a prevalent metabolic condition that is expected to impact 380 million individuals globally by 2025. Despite being highly accurate, the... Read more

Molecular Diagnostics

view channel
Image: Researchers have identified the origin of subset of autoantibodies that worsen lupus (Photo courtesy of Pexels)

Lupus Biomarker Testing Could Help Identify Patients That Need Early and Aggressive Treatment

Systemic lupus erythematosus (SLE) is an autoimmune disease that occurs when the body's antibodies, which usually protect against infections, attack healthy cells and proteins. These autoantibodies can... Read more

Immunology

view channel
Image: A genetic test could guide the use of cancer chemotherapy (Photo courtesy of Pexels)

Genetic Test Predicts Whether Bowel Cancer Patients Can Benefit From Chemotherapy

Late-stage bowel cancer patients usually undergo a series of chemotherapies and targeted medicines for cancer treatment. However, the responses to the last-line chemotherapy treatment trifluridine/tipiracil... Read more

Microbiology

view channel
Image: Use of DBS samples can break barriers in hepatitis C diagnosis and treatment for populations at risk (Photo courtesy of Pexels)

DBS-Based Assay Effective in Hepatitis C Diagnosis and Treatment for At Risk Populations

In a bid to eliminate viral hepatitis as a public health threat by 2030, the World Health Organization (WHO) has put forth a proposed strategy. To this end, researchers at the Germans Trias i Pujol Research... Read more

Pathology

view channel
Image: New research has opened a path for fast and accurate cancer diagnosis (Photo courtesy of Imagene)

AI-Based Image Analysis Software Profiles Cancer Biomarkers in Real Time

Lung cancer is the most widespread type of cancer worldwide, resulting in approximately 1.76 million fatalities annually. Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancer diagnoses... Read more

Technology

view channel
Image: Live view of non-fluorescent specimens using the glowscope frame (Photo courtesy of Winona State University)

Device Converts Smartphone into Fluorescence Microscope for Just USD 50

Fluorescence microscopes are utilized to examine specimens labeled with fluorescent stains or expressing fluorescent proteins, like those tagged with green fluorescent protein. However, since these microscopes... Read more

Industry

view channel
Image: The global antimicrobial resistance diagnostics market size is expected to reach USD 5.7 billion by 2028 (Photo courtesy of Pexels)

Global Antimicrobial Resistance Diagnostics Market Driven by Increasing Hospital-Acquired Infections

Antimicrobial drugs are intended to counteract the harmful effects of microbes and promote a healthy life. However, their excessive use can result in the development of resistance, commonly referred to... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.